What was recalled
The U.S. Food and Drug Administration (FDA) has issued a Class I recall involving medical devices distributed by AVID Medical, Inc. Specifically, the company is recalling its Haylard BASIC BIOPSY TRAY kits. This action targets a specific subset of inventory that presents a significant risk to patient safety due to compromised components within the sterile packaging. The product in question is identified under the brand name AVID Medical and carries the model or item number PM415. For those who may have access to detailed tracking systems or supply chain records, the Unique Device Identifier (UDI-DI) for this specific kit is 10809160322154. It is important to note that a Class I classification by the FDA indicates that this is the most serious category of recall, used in situations where there is a reasonable probability that the use of the product will cause serious adverse health consequences or death.
The scope of this recall is defined by precise lot numbers and distribution patterns. The affected kits are those containing specific lots of Sodium Chloride ampules that were themselves subject to a separate recall by Spectra Medical. The particular lot numbers of the Sodium Chloride ampules included in the AVID Medical kits are AB5002 and AB4003. Consequently, the Haylard BASIC BIOPSY TRAY kits (Model PM415) that contain these specific ampule lots are the ones under recall. The kit lots affected by this action are 1652485, 1656642, 1667835, 1676219, 1682251, and 1691940. If you are a healthcare provider or facility manager checking your inventory, these six kit lot numbers are the critical identifiers to cross-reference against your stock.
Regarding where and when this product was sold or distributed, the recall focuses on domestic distribution within the United States. The affected units were distributed to locations in Illinois (IL), North Carolina (NC), Virginia (VA), and Wyoming (WY). While the specific dates of sale are not detailed in the initial FDA notification, the recall itself was initiated on August 10, 2026. This means that any inventory from these states falling within the specified lot numbers should be considered suspect immediately. The recall does not appear to cover international distribution or other U.S. states outside of this specific pattern, but given the nature of medical supply chains, verification with your supplier is essential. The remedy for this recall has not yet been stated in the official record, leaving healthcare facilities and patients to await further instructions on how these kits will be retrieved or replaced.
Understanding exactly what was recalled helps in isolating the risk. This is not a broad recall of all AVID Medical products, nor is it a recall of all Haylard trays. It is strictly limited to the PM415 model containing the specific Spectra Medical Sodium Chloride ampule lots AB5002 and AB4003. By focusing on these precise identifiers, healthcare providers can quickly determine if their current stock is affected without unnecessarily discarding safe inventory. The limitation to four states suggests a targeted distribution event, which may help in tracing exactly where these kits ended up. If you are in IL, NC, VA, or WY and have received Haylard BASIC BIOPSY TRAY kits (PM415) with the listed lot numbers since before August 10, 2026, you are holding a product that must be addressed according to FDA guidance.
The hazard, explained
When you look at the FDA’s notice regarding AVID Medical, Inc.’s recall of the Haylard BASIC BIOPSY TRAY (Model/Item Number PM415), the core issue isn’t about the mechanical function of the biopsy needle itself. Instead, it centers on a critical component within the kit: the Sodium Chloride ampule. The FDA has classified this as a Class I recall, which is the agency’s most serious category. This designation is reserved for situations where there is a reasonable probability that the use of the product will cause serious adverse health consequences or death. In plain terms, this means the potential for harm is significant enough that immediate attention is required.
The specific mechanism of failure here involves two distinct but related problems: product quality and sterility. The recalled kits contain Sodium Chloride ampules that were subject to a separate recall by Spectra Medical. While we do not have the full technical report detailing exactly how these ampules failed, in medical device manufacturing, "product quality issues" with sterile saline solutions typically point to one of two dangerous outcomes. First, the integrity of the glass or plastic seal may be compromised. If an ampule has a microscopic crack or a weak spot in its seal, it is no longer truly sterile. Second, even if the seal appears intact, manufacturing defects can lead to contamination during the filling process. In either scenario, the fluid inside the tray, which is supposed to be pure and safe for medical use, may contain bacteria, particulates, or other contaminants.
Why does this matter for a biopsy? A biopsy involves inserting a needle through the skin into tissue to remove a sample. This procedure creates an open wound and a direct pathway for anything on the surface of the needle or in the fluids used during the procedure to enter the body’s internal tissues. If the Sodium Chloride ampule in the tray is contaminated, that impure fluid can be introduced directly into the patient’s body during the preparation or irrigation phase of the biopsy. This bypasses the body’s natural external defenses (like the skin) and places pathogens directly into sensitive areas.
The potential harm from this mechanism is serious infection. If a patient uses a kit with compromised sterility, they risk introducing bacteria such as Staphylococcus or other hospital-acquired pathogens into their tissue. This can lead to local infections at the biopsy site, which may spread to the bloodstream (sepsis), cause abscesses, or require additional surgical intervention to clean out the infected area. For patients who are already undergoing medical procedures and may have compromised immune systems due to underlying conditions, the risk is even higher. The FDA’s classification underscores that this is not a minor inconvenience; it is a direct threat to patient safety through the breach of sterility protocols that are designed to keep invasive procedures safe.
Who is most at risk
To understand who is truly at risk from this recall, we first need to clarify exactly what this product is and how it enters the picture of patient care. The AVID Medical Haylard BASIC BIOPSY TRAY (Model PM415) is not a consumer good you would purchase at a pharmacy or find in a home medicine cabinet. It is a specialized medical device kit designed for use by healthcare professionals, specifically within clinical settings such as hospitals, outpatient surgical centers, and diagnostic imaging suites. Therefore, the primary group "at risk" here is not the general public walking down the street, but rather patients who are scheduled to undergo biopsy procedures that utilize this specific tray. If you have never had a tissue sample taken for medical diagnosis, this recall does not directly impact your life.
The individuals most vulnerable to the consequences of this recall are those who have undergone or are scheduled to undergo a biopsy using the affected kits. The hazard stems from Sodium Chloride ampules included in the tray that were subject to a separate recall by Spectra Medical due to potential quality and sterility issues. When a medical instrument intended to be sterile is compromised, the primary danger is infection. For patients whose immune systems are already weakened by existing illnesses, recent surgeries, or treatments like chemotherapy, even a minor breach in sterility can lead to serious complications. These patients rely on the absolute integrity of every component in their surgical tray because their bodies have less capacity to fight off introduced pathogens.
While the recall notice lists distribution patterns in Illinois, North Carolina, Virginia, and Wyoming, it is important to note that a Class I classification by the FDA indicates a situation where use of the product could cause serious adverse health consequences or death. This highest level of concern suggests that the risk is not theoretical. Patients in these states who received care at facilities that stocked this specific lot are potentially exposed. The vulnerability is further compounded by the fact that sterility issues may not be visible to the naked eye. A patient might receive a biopsy kit that looks perfectly normal on the outside, yet the internal Sodium Chloride solution could be contaminated or of substandard quality. This lack of visible warning makes every patient who uses this kit equally at risk until proven otherwise through proper verification.
Additionally, healthcare providers themselves are part of the risk equation, though in a different capacity. Doctors, nurses, and technicians who handle these kits must ensure they do not open or use the compromised trays. If a medical professional inadvertently uses one of the recalled lots (such as 1652485, 1656642, 1667835, 1676219, 1682251, or 1691940), they not only put their patient at risk but also face significant professional and legal liability. The chain of safety relies on both the supplier and the medical facility to catch this error before it reaches the patient. Therefore, while the patient is the ultimate victim of any potential harm, the immediate responsibility for mitigating risk lies with the healthcare system's inventory management processes.
How to tell if you have the recalled item
Identifying whether your medical supplies are part of this specific FDA recall requires careful attention to the details printed on the packaging. Because this recall involves a specialized medical device—the Haylard BASIC BIOPSY TRAY manufactured by AVID Medical, Inc.—it is not something you would typically find in a general retail store or a standard home medicine cabinet. Instead, these kits are distributed through professional medical channels and may be held by healthcare providers, clinics, or potentially patients who have been supplied directly with this specific item. To determine if you possess the affected product, you need to locate the physical kit and examine two critical areas: the primary label on the outer packaging and the internal documentation or individual component labels.
First, look for the brand name "AVID Medical" prominently displayed on the box or tray. Next, identify the specific model or item number associated with the kit. The recall applies exclusively to the Haylard BASIC BIOPSY TRAY with Model/Item Number PM415. If your kit has a different model number, it is not part of this recall. Alongside the model number, you must verify the Universal Device Identifier (UDI-DI), which serves as a unique digital fingerprint for the product. For this recall, the UDI-DI is 10809160322154. If you cannot find this string of numbers on the packaging, it is highly unlikely that your item is one of the recalled units.
The most crucial step in verification involves checking the lot numbers, as the recall is limited to specific production batches linked to a supplier issue. You need to check two sets of lot numbers: the kit’s own lot number and the lot number of the Sodium Chloride ampules contained within it. The recalled kits have the following lot numbers: 1652485, 1656642, 1667835, 1676219, 1682251, and 1691940. If your kit’s lot number does not match one of these exactly, it is safe from this specific recall event.
Additionally, even if you have a kit with a matching lot number, you must confirm the source of the Sodium Chloride ampules inside. The hazard stems from ampules subject to recall by Spectra Medical. You need to look for the specific recalled Sodium Chloride Ampule Lot numbers: AB5002 and AB4003. If your kit contains ampules with different lot numbers, it is not affected. It is important to note that this recall was issued on August 10, 2026, and distribution was limited to domestic locations in Illinois (IL), North Carolina (NC), Virginia (VA), and Wyoming (WY). If you acquired the item outside of these states or prior to the recall notice without being notified by your provider, double-check the labels carefully. When in doubt, do not use the product; show the lot numbers to your healthcare provider or pharmacist for confirmation.
What to do — step by step
Because the official remedy for this specific recall has not been explicitly stated by AVID Medical, Inc. or the FDA in the provided data, you cannot rely on standard return or refund instructions that typically accompany such announcements. This silence does not mean the situation is less serious; rather, it means you must exercise heightened caution and proactive communication. When a manufacturer withholds specific remediation details, the default assumption for medical devices involving sterility concerns must be strict avoidance until further notice.
Step 1: Immediately cease use of the product. The primary hazard here involves potential quality and sterility issues linked to Sodium Chloride ampules supplied by Spectra Medical. Since these ampules are part of a kit used for biopsies, any compromise in sterility poses a direct risk of infection or tissue damage during a medical procedure. Do not open, inspect, or attempt to use the Haylard BASIC BIOPSY TRAY (Model PM415) if you have it in your possession. Even if the packaging appears intact, the internal sodium chloride component may be compromised due to the recall of the Spectra Medical lot. Treat the device as potentially unsafe until you receive direct clarification from the manufacturer.
Step 2: Identify your specific inventory using the lot numbers. If you are a healthcare provider or facility that has received this kit, verify whether your stock matches the recalled items. The recall affects kits with Lot numbers 1652485, 1656642, 1667835, 1676219, 1682251, and 1691940. Crucially, you must check if these kits contain the Sodium Chloride Ampule with Lot number AB5002 or AB4003. If your inventory does not match these specific lot numbers, the risk may be lower, but you should still document your findings in case future updates expand the scope.
Step 3: Contact AVID Medical, Inc. directly for instructions. Since the standard remedy (such as a prepaid return label or a direct refund) is not listed, you must initiate contact to determine the next steps. Reach out to AVID Medical’s customer service or quality assurance department using the contact information provided in their official recall notice or on their corporate website. Do not assume that the product can be used for future procedures. Ask specifically whether they are issuing a replacement kit, offering a refund, or requiring you to return the defective units for destruction.
Step 4: Quarantine any affected units. If you have confirmed possession of the recalled kits, do not attempt to resell them, donate them, or dispose of them in regular trash. Isolate these items in a secure area within your facility to prevent accidental use by staff or patients. Label them clearly as "RECALLED - DO NOT USE" to ensure that no one mistakenly incorporates them into patient care protocols while you await further instructions from the manufacturer.
Step 5: Monitor official channels for updates. Given that this is a Class I recall, which represents the highest risk category where use of the product could cause serious adverse health consequences or death, staying informed is critical. Check the FDA’s website and AVID Medical’s communications regularly. The lack of a stated remedy today may change tomorrow as the company clarifies their logistics for handling the Spectra Medical component issue.
Your refund, repair, or replacement options
When a medical device recall occurs, the most immediate question for patients and healthcare providers is often, "What happens next?" In this specific case involving AVID Medical, Inc., the recall of the Haylard BASIC BIOPSY TRAY presents a unique situation because the official FDA record does not explicitly state a standard remedy such as a refund, replacement, or repair. While it might be surprising to see a Class I recall without a clearly listed corrective action in the public summary, this is not uncommon for certain types of supply chain issues. The primary hazard here stems from the Sodium Chloride ampules included in the kits, which were subject to a separate recall by Spectra Medical due to potential quality and sterility concerns. Because the issue is tied to the integrity of these specific components rather than a manufacturing defect in the tray itself, the standard "return for credit" process may not apply in the traditional sense.
Instead of expecting an automatic refund or replacement kit sent to your door, the remedy relies heavily on containment and quarantine. The core instruction implicit in this type of recall is that you should stop using any affected kits immediately. If you are a healthcare facility, such as a hospital or clinic in Virginia, North Carolina, Illinois, or Wyoming, you must identify the specific lots mentioned in the official notice—specifically Kit Lots 1652485, 1656642, 1667835, 1676219, 1682251, and 1691940—and remove them from your inventory. The "remedy" here is effectively the cessation of use to prevent any potential harm from non-sterile or compromised Sodium Chloride ampules. You should not attempt to open these kits or use the contents for patient care.
If you are a consumer who may have purchased this device, or if you are a medical professional holding one of these kits, do not assume that AVID Medical will issue a check or send a new product automatically. The absence of a stated remedy in the FDA summary suggests that contact with the manufacturer is necessary to determine the specific logistical steps. You will need to reach out to AVID Medical directly to inquire about their internal return policy for these specific lots. It is possible that they may offer a replacement for future orders or provide guidance on how to dispose of the recalled units safely, but this will require direct communication.
To find the correct contact information, you should refer to the full FDA recall press release or the official AVID Medical website. Since the distribution pattern includes domestic locations in IL, NC, VA, and WY, ensure that your facility’s procurement department is aware of this recall so they can track any incoming shipments of these specific lots. If you are a patient who had a biopsy using one of these trays, please consult your healthcare provider immediately. They will be able to confirm whether the specific kit used was part of the recalled lot and advise on any necessary follow-up care. The safety of the sterility barrier is paramount, so erring on the side of caution by not using the product is the most important step you can take while waiting for further instructions from the manufacturer.
In summary, while a financial refund or a direct replacement kit is not explicitly guaranteed in this recall notice, the primary "option" available to you is to quarantine the device and contact AVID Medical for specific disposal or return instructions. Always verify the lot numbers carefully against the official list provided by the FDA to ensure you are dealing with the correct recalled items. When in doubt, do not use the product and seek professional medical advice if it has already been used in a procedure.
What can happen if you ignore it
When a medical device is recalled due to sterility and quality issues, the temptation to simply keep using what you have on hand can be strong, especially if you are in the middle of a treatment plan or if replacing the item feels like an administrative burden. However, ignoring this specific recall from AVID Medical, Inc. carries significant and tangible risks that go far beyond simple inconvenience. The core issue here is not a mechanical failure or a software glitch; it is a fundamental breach of the sterile barrier. For a product like the Haylard BASIC BIOPSY TRAY, which is designed to facilitate tissue sampling, maintaining a sterile environment is not just a regulatory checkbox—it is the primary safeguard against introducing pathogens directly into the human body.
If you continue to use kits containing the recalled Sodium Chloride ampules from Spectra Medical (lots AB5002 and AB4003), you are risking exposure to non-sterile solutions. Sodium chloride, or saline, is typically used to flush catheters, clean wound sites, or dilute medications during a biopsy procedure. When the sterility of these ampules is compromised, they can serve as a vector for bacteria, fungi, or other microorganisms. In a clinical setting, this might result in a localized infection at the biopsy site, presenting as redness, swelling, pain, or pus formation. While some minor infections can be treated with antibiotics, the consequences can escalate rapidly. For patients with compromised immune systems, the elderly, or those with underlying health conditions, what starts as a minor irritation can progress to a serious systemic infection, such as sepsis, which is a life-threatening response to infection.
Beyond the immediate risk of infection, there is the issue of product quality. The recall notes "potential for product quality issues," which suggests that the saline may not meet the specified purity or concentration standards. Using saline that is contaminated with particulate matter or has an incorrect osmolarity can cause additional harm. For instance, if the solution is hypertonic or hypotonic due to manufacturing defects, it could damage cells at the site of application, leading to tissue irritation or necrosis. Furthermore, if the ampule itself is compromised, there is a risk of glass shards or plastic fragments entering the patient’s body during use, causing physical trauma or embolisms.
It is also important to consider the legal and medical record implications. If you experience an adverse event after ignoring a Class I recall, it can complicate your medical care. Healthcare providers may be hesitant to attribute subsequent complications to the device if they know it was part of a known recalled lot, potentially delaying appropriate treatment. More importantly, by using a known defective product, you are bypassing the safety net that the FDA and the manufacturer have put in place. The recall is not a suggestion; it is a critical intervention designed to prevent harm before it occurs. Ignoring it shifts the risk entirely onto you, without any guarantee of support or remedy from the manufacturer if something goes wrong.
Finally, consider the broader impact on public health. While this might seem like an individual choice, widespread non-compliance with medical device recalls can lead to outbreaks of healthcare-associated infections that strain hospital resources and endanger other patients. The distribution pattern for this recall includes Virginia, among other states, meaning that local hospitals and clinics may be affected. Your decision to use a recalled kit does not exist in a vacuum; it contributes to the overall burden on the healthcare system. The safest, most responsible path is to stop using the device immediately and contact AVID Medical or your healthcare provider for instructions on how to safely dispose of the item and obtain a replacement. The short-term hassle of following the recall procedure is negligible compared to the potential long-term health consequences of ignoring it.
Staying safe: broader tips
While this specific recall addresses a particular batch of biopsy trays from AVID Medical, Inc., the underlying principle here—vigilance regarding medical supply chains and sterility—is applicable to all consumers who rely on medical devices. Whether you are managing chronic conditions at home or preparing for minor procedures, understanding how to protect your health extends far beyond reacting to a single notification. The most effective strategy for staying safe is proactive education and routine maintenance of your own safety habits.
First, make it a regular habit to check for recalls on the products you use daily. Many people do not realize that medical devices, from blood pressure monitors to insulin pumps, are subject to the same rigorous oversight as pharmaceuticals. The U.S. Food and Drug Administration (FDA) maintains a public database of all Class I, II, and III device recalls. You can sign up for email alerts specific to your region or the types of devices you own. By staying informed through official government channels rather than relying solely on news headlines, you ensure that you are not caught off guard by potential quality issues, such as the sterility concerns highlighted in this recent AVID Medical recall.
Second, always verify the integrity of your medical supplies before use. For any device that requires sterility, such as biopsy trays, catheters, or surgical kits, inspect the packaging for any signs of tampering, punctures, or moisture damage. If a kit has been open or its seal is compromised, do not attempt to "clean" it and reuse it. Sterility is not just about visible dirt; it involves microscopic contamination that can lead to serious infections. When in doubt, discard the item and seek a new one from a reputable supplier. This simple step of visual inspection can prevent complications that might otherwise require medical intervention.
Finally, understand the difference between Class I and higher-class recalls. A Class I recall, like the one issued for the Haylard BASIC BIOPSY TRAY, typically involves products where use could lead to serious adverse health consequences or death. However, many devices are classified as Class II or III based on their risk profile. For all medical devices, read the manufacturer’s instructions for use (IFU) carefully. These documents provide critical guidance on proper storage, handling, and maintenance. For example, some devices require specific temperature ranges to maintain efficacy, while others need regular calibration to ensure accuracy. By treating your medical equipment with the same respect you would give to a car or a home appliance—regular checks, proper care, and timely updates—you significantly reduce your risk of injury or health complications. Stay curious, stay informed, and never hesitate to contact your healthcare provider if you have questions about the safety of your equipment.